| 1 |
29701105 | A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure. | 2018 May |
2 |
| 2 |
24958603 | Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE? | 2014 Aug |
2 |
| 3 |
23608658 | Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers. | 2013 Jun |
1 |
| 4 |
23690239 | A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2. | 2013 Oct |
1 |
| 5 |
22566498 | Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. | 2012 Jun |
1 |
| 6 |
21818547 | Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients. | 2011 Dec |
1 |
| 7 |
21881353 | Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery--investigation using a candesartan change-over study. | 2011 |
1 |
| 8 |
19648902 | Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme. | 2010 Jan |
1 |
| 9 |
20102922 | Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation. | 2010 Jan 15 |
1 |
| 10 |
20511125 | Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. | 2010 Jun |
1 |
| 11 |
21219847 | Ambulatory blood pressure, endothelial perturbation, and microvascular complications in type 2 diabetes. | 2010 Jun |
1 |
| 12 |
17378373 | Effects of candesartan for middle-aged and elderly women with hypertension and menopausal-like symptoms. | 2006 Dec |
2 |
| 13 |
15983242 | Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. | 2005 Jul 5 |
1 |
| 14 |
15086486 | Plasma aldosterone concentration in the patient with diabetes mellitus. | 2004 Apr |
1 |
| 15 |
12140730 | AT(1)-receptor blockade and the kidney: importance of non-ACE pathways in health and disease. | 2002 Aug |
1 |
| 16 |
12397699 | [Comparison of ARB and ACEI for renoprotection in chronic glomerulonephritis]. | 2002 Oct |
1 |
| 17 |
12451320 | Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure. | 2002 Dec |
1 |
| 18 |
11260405 | Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. | 2001 Apr |
1 |
| 19 |
11059632 | Achieving quality 24-h blood pressure control with candesartan cilexetil. | 2000 |
1 |
| 20 |
11082152 | Renal hemodynamic and hormonal responses to the angiotensin II antagonist candesartan. | 2000 Nov |
2 |
| 21 |
28425793 | Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers? | 2000 |
1 |
| 22 |
28425796 | Achieving Quality 24-h Blood Pressure Control with Candesartan Cilexetil. | 2000 |
1 |
| 23 |
10404959 | Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan. | 1999 Apr |
1 |
| 24 |
10577995 | Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators. | 1999 Nov 30 |
1 |